NDRG1 in Cancer: A Suppressor, Promoter, or Both?
N-myc downregulated gene-1 (NDRG1) has been variably reported as a metastasis suppressor, a biomarker of poor outcome, and a facilitator of disease progression in a range of different cancers. NDRG1 is poorly understood in cancer due to its context-dependent and pleiotropic functions. Within breast...
Main Authors: | Vaibhavi Joshi, Sunil R. Lakhani, Amy E. McCart Reed |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/23/5739 |
Similar Items
-
NDRG1 is a prognostic biomarker in breast cancer and breast cancer brain metastasis
by: Vaibhavi Joshi, et al.
Published: (2024-03-01) -
The Function of N-Myc Downstream-Regulated Gene 2 (NDRG2) as a Negative Regulator in Tumor Cell Metastasis
by: Ki Won Lee, et al.
Published: (2022-08-01) -
DNMT family induces down-regulation of NDRG1 via DNA methylation and clinicopathological significance in gastric cancer
by: Xiaojing Chang, et al.
Published: (2021-09-01) -
Clinical Diagnostic and Prognostic Potential of NDRG1 and NDRG2 in Hepatocellular Carcinoma Patients
by: Shaohua Xu, et al.
Published: (2022-06-01) -
Editorial: Molecular mechanisms in breast cancer progression and metastasis
by: Monica Fedele, et al.
Published: (2022-08-01)